Filters close
4-Apr-2024 4:05 PM EDT
Youths with Mood Disorders 30 Percent Less Likely to Acquire Driver’s License Than Peers
Children's Hospital of Philadelphia

Researchers found that teens and young adults with mood disorders, such as depression and bipolar disorder, were 30% less likely to obtain their driver’s license than peers without such disorders. Additionally, those youths with mood disorders experienced a slightly elevated risk of crashing.

access_time Embargo lifts in 2 days
This news release is embargoed until 10-Apr-2024 11:00 AM EDT Released to reporters: 8-Apr-2024 9:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Apr-2024 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Mar-2024 10:05 AM EDT
Chop Researchers Find Branched Chain Amino Acid Supplementation May Aid in Concussion Recovery
Children's Hospital of Philadelphia

In the first clinical trial of a targeted pharmacologic therapeutic for mild traumatic brain injury in pediatric patients, scientists have found preliminary evidence that adolescents and young adults with concussion who take a specific formulation of branched chain amino acid (BCAA) supplements after injury experience faster symptom reduction and return to physical activity.

13-Mar-2024 2:05 PM EDT
CHOP Researchers Discover Key Metabolic Process Responsible for Rapid Immune Responses
Children's Hospital of Philadelphia

Researchers identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens, vaccines, or diseased cells grow and divide faster than other cells.

Released: 27-Sep-2023 9:50 AM EDT
CHOP Researchers Improve Fitness of Cells Used in Cell Transplants
Children's Hospital of Philadelphia

A readily available, inexpensive small molecule drug can improve the fitness of hematopoietic stem and progenitor cells (HSPCs) that are modified outside of the body, potentially improving the success of procedures like ex vivo gene therapy, according to a new study by researchers at Children’s Hospital of Philadelphia (CHOP).

Released: 15-Aug-2023 2:05 PM EDT
CHOP Researchers Develop Versatile and Low-Cost Technology for Targeted Long-read RNA Sequencing
Children's Hospital of Philadelphia

In a development that could accelerate the discovery of new diagnostics and treatments, researchers at Children’s Hospital of Philadelphia (CHOP) have developed a versatile and low-cost technology for targeted sequencing of full-length RNA molecules.

7-Aug-2023 3:05 PM EDT
Researchers Find COVID-19 Causes Mitochondrial Dysfunction in Heart and Other Organs
Children's Hospital of Philadelphia

A multi-institutional consortium of researchers has found that the genes of the mitochondria, the energy producers of our cells, can be negatively impacted by the virus, leading to dysfunction in multiple organs beyond the lungs. These findings suggest new approaches for treating COVID-19.

24-Jul-2023 11:10 AM EDT
CHOP and Penn Medicine Researchers Develop “In Vivo” RNA-based Gene Editing Model for Blood Disorders
Children's Hospital of Philadelphia

In a step forward in the development of genetic medicines, researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have developed a proof-of-concept model for delivering gene editing tools to treat blood disorders, allowing for the modification of diseased blood cells directly within the body. If translated into the clinic, this approach could expand access and reduce the cost of gene therapies for blood disorders, many of which currently require patients receive chemotherapy and a stem cell transplant. The findings were published today in the journal Science.

20-Jul-2023 10:30 AM EDT
CHOP Researchers Validate Pediatric “Allergic March” in Largest National Study of its Kind
Children's Hospital of Philadelphia

In the largest study of its kind, researchers from Children’s Hospital of Philadelphia (CHOP) used electronic health record (EHR) data from more than 200,000 pediatric patients to describe patterns of pediatric allergies across the United States, validating a population-level pattern of allergy development known as the “allergic march,” in which allergies first present as eczema, followed by food allergies, asthma, and environmental allergies. The researchers also found that a rare food allergy called eosinophilic esophagitis (EoE), which has historically been considered a disease affecting primarily White males, is more common among non-White patients than previously reported.

Released: 20-Jul-2023 10:15 AM EDT
CHOP Researchers Develop Tool for Helping Predict Alzheimer’s Risk in Various Ethnic Populations
Children's Hospital of Philadelphia

Using data from diverse populations around the world, researchers have developed an algorithm to help predict the risk of developing Alzheimer’s disease based on genetic information in patients with a wide variety of ethnic backgrounds. While additional ethnicities should be included in future studies, this work aims to eliminate disparities in diagnosis of the disease.

18-Jul-2023 10:20 AM EDT
CHOP and Penn Researchers Find Behavioral Economics Strategies Can Help Patients Quit Smoking After a Cancer Diagnosis
Children's Hospital of Philadelphia

Researchers found that cancer patients who continued to smoke after their diagnosis were significantly more likely to receive treatment for tobacco use when “nudges” to provide tobacco treatment were directed at clinicians through the electronic health record.

17-Jul-2023 10:00 AM EDT
CHOP Researchers Reveal How NSAIDs Worsen C. difficile Infections
Children's Hospital of Philadelphia

Why do nonsteroidal anti-inflammatory drugs (NSAIDs) exacerbate gastrointestinal infections by Clostridioides difficile, the leading cause of antibiotic-associated diarrhea worldwide? In a new paper published in Science Advances, researchers at Children’s Hospital of Philadelphia (CHOP) have begun to answer that question, showing that NSAIDs disrupt the mitochondria of cells lining the colon, sensitizing them to damage by pathogenic toxins.

Released: 6-Jul-2023 10:30 AM EDT
Interpersonal and Structural Stigma Toward Sexual Minority Youth Create Mental Health Challenges, Increased Suicide Risk
Children's Hospital of Philadelphia

Researchers found that lesbian, gay and bisexual (LGB) youth experienced more interpersonal discrimination based on others perceiving them as lesbian, gay, or bisexual and were four times more likely to attempt suicide. Additionally, LGB youth living in areas of the country with more structural stigma experienced a larger mental health burden than their peers. These findings stress the urgency for addressing interpersonal discrimination and structural stigma toward LGB youth.

   
Released: 21-Jun-2023 1:25 PM EDT
As Summer Heats Up, CHOP Researchers Study Caregiver Attitudes Toward Pediatric Vehicular Heatstroke
Children's Hospital of Philadelphia

Despite prevention efforts, a child dies of heatstroke in a vehicle approximately once every 10 days. According to a new survey, most caregivers report they never leave children in their vehicles for any length of time. However, the attitudes toward those who were thought to put their children at risk for pediatric vehicular heatstroke are largely negative, which may cause some caregivers not to adopt important mitigation efforts to prevent these tragic deaths.

Released: 13-Jun-2023 2:55 PM EDT
CHOP Researchers Develop Universal MHC Molecules that Can be Produced Rapidly at Scale
Children's Hospital of Philadelphia

Researchers from Children’s Hospital of Philadelphia (CHOP) have engineered stable, universal MHC-I molecules that can be produced rapidly at scale, allowing researchers not only to develop vaccines and immunotherapies more quickly but also to identify molecules that can work broadly across the population. The findings were published today in the Proceedings of the National Academy of Sciences.

Released: 12-Jun-2023 12:20 PM EDT
Self-Esteem of Kids with Short Stature Tied to Social Supports, Not Height
Children's Hospital of Philadelphia

Challenging the assumption that short stature negatively impacts children and adolescents’ self-esteem, a new study by researchers at Children’s Hospital of Philadelphia (CHOP) has found that in otherwise healthy short youth, quality of life and self-esteem are associated with coping skills and how supported they feel and not the degree of their short stature. The findings were published in The Journal of Pediatrics.

30-May-2023 9:45 AM EDT
CHOP Researchers Use “Deep Sequencing” to Identify Several Previously Undescribed Genetic Variants in Vascular Anomalies
Children's Hospital of Philadelphia

Researchers recently discovered that extremely thorough “deep sequencing” of the genome in tissue samples and cell-free DNA of patients with potentially life-threatening vascular anomalies captured several genetic variants related to disease that were not captured with conventional genetic sequencing methods. More than 60% of patients saw an improvement in their condition after being placed on targeted therapies related to these newly found genetic variants.

30-May-2023 10:05 AM EDT
First-of-its-Kind Open-Analysis Platform for Pediatric Brain Tumors Provides Robust Data Resource for Childhood Cancer Research
Children's Hospital of Philadelphia

Researchers have partnered to create a first-of-its-kind open-source, reproducible analysis platform for pediatric brain tumors. With the help of thousands of genomically sequenced samples, researchers have used this platform to identify initial findings about genetic variants associated with poorer outcomes that could help guide future diagnostic and therapeutic advances.

23-May-2023 10:05 AM EDT
CHOP Researchers Show that IgA Fine Tunes the Body’s Interactions with Microbes
Children's Hospital of Philadelphia

A new study by researchers at Children’s Hospital of Philadelphia (CHOP) has demonstrated that IgA acts as a “tuner” that regulates the number of microbes the body sees every day, restraining the systemic immune response to these commensal microbes and limiting the development of systemic immune dysregulation.

Released: 24-May-2023 9:25 AM EDT
CHOP Researchers Comprehensively Assess the Safety of Using Your Head in Youth Soccer
Children's Hospital of Philadelphia

Repeatedly heading a soccer ball has been previously associated with negative long-term brain health for professional players. However, a new study found that a small number of repeated soccer headers equivalent to a throw-in did not cause immediate neurophysiological deficits for teens, suggesting that limited soccer heading exposure in youth sports may not result in irreversible harm if players are properly trained.

Released: 17-May-2023 1:15 PM EDT
New Computational Tool Identifies Novel Targets for Cancer Immunotherapy
Children's Hospital of Philadelphia

Researchers at Children’s Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets. The tool, called “Isoform peptides from RNA splicing for Immunotherapy target Screening” (IRIS), was described in a paper published today in the Proceedings of the National Academy of Sciences.

25-Apr-2023 10:05 AM EDT
Children’s Hospital of Philadelphia, Princeton Researchers Identify Novel Genetic Disorder
Children's Hospital of Philadelphia

Researchers have discovered a novel genetic disorder associated with neurodevelopmental differences. The discovery identified the disorder in 21 families from all over the world.

Released: 13-Apr-2023 12:00 PM EDT
Researchers Find Earlier Intervention Leads to Greater Improvements in Young Children on the Autism Spectrum
Children's Hospital of Philadelphia

Researchers have demonstrated that starting intervention coaching parents of autistic toddlers as early as 18 months leads to better gains in language, social communication, and daily living skills.

3-Apr-2023 3:30 PM EDT
CHOP-led Study Identifies Two Different Regulatory T Cell Populations
Children's Hospital of Philadelphia

A regulatory class of human T cells descends from two different origins, one that relates to autoimmunity and one that relates to protective immunity, according to a new study led by Children’s Hospital of Philadelphia (CHOP). The findings, published today in Science Immunology, could pave the way for new treatments for autoimmune diseases that target the immune system selectively.

Released: 6-Apr-2023 9:55 AM EDT
CHOP Researchers Use Novel Technique to Analyze 53 Million Points of Clinical Data
Children's Hospital of Philadelphia

Researchers were able to analyze 53 million patient notes from more than 1.5 million individual patients to identify similarities in their medical histories that can help pinpoint potential risks for developing future diseases and the trajectory of those conditions. This method of identifying phenotypic similarities exceeds the capacity any other current computational models.

3-Apr-2023 3:00 PM EDT
CHOP Researchers Reveal Complex Assembly Process Involved in DNA Virus Replication
Children's Hospital of Philadelphia

In a twist on the question, “Which came first, the chicken or the egg?”, scientists have long faced a similar question about how human adenovirus replicates: “Which comes first, assembly of the viral particle, or packaging of the viral genome?” Now, in a new study published today in Nature, researchers at Children’s Hospital of Philadelphia (CHOP) have answered that question, showing that viral proteins use a process called phase separation to coordinate production of viral progeny.

31-Mar-2023 11:00 AM EDT
Researchers Show Lorlatinib is Safe and Effective for Patients with ALK-Driven Relapsed/Refractory High-Risk Neuroblastoma
Children's Hospital of Philadelphia

In a significant step for the treatment of neuroblastoma, an international group of researchers led by Children’s Hospital of Philadelphia (CHOP), Winship Cancer Institute of Emory University and the New Approaches to Neuroblastoma Therapy (NANT) Consortium has shown that the targeted therapy lorlatinib is safe and effective in treating high-risk neuroblastoma.

21-Mar-2023 12:05 PM EDT
CHOP Researchers Develop First-Of-Its-Kind Prediction Model for Newborn Seizures
Children's Hospital of Philadelphia

Researchers have developed a prediction model that determines which newborn babies are likely to experience seizures in the Neonatal Intensive Care Unit (NICU). This model could be incorporated into routine care to help the clinical team decide which babies will need electroencephalograms (EEGs) and which babies can be safely managed in the Neonatal Care Unit without monitoring through EEGs. This would allow families and providers to care for babies without intrusive and unnecessary procedures.

17-Mar-2023 3:00 PM EDT
CHOP Researchers Find Strong Adolescent-Parent Relationships Lead to Better Long-term Health Outcomes in Young Adults
Children's Hospital of Philadelphia

Researchers have found that adolescents who report strong relationships with their parents have better long-term health outcomes. Study findings suggest that investments in improving parent–adolescent relationships could help improve general health, mental health and sexual, health while also reducing substance use in young adulthood.

   


close
0.20619